View Post

Newly Approved Targeted Therapy Paves the Way for Patients With Advanced Bladder Cancer

In Clinical Trials by Barbara Jacoby

By: Katie Kosko From: curetoday.com Patients with advanced bladder cancer and a specific gene mutation have a promising new treatment option, according to phase 2 study findings published in the New England Journal of Medicine. The international trial was led by researchers from The University of Texas MD Anderson Cancer Center and included 99 patients with metastatic urothelial carcinoma or …

View Post

Immunotherapy Expands Treatment Options for Metastatic Bladder Cancer

In Clinical Trials by Barbara Jacoby

By: Danielle Ternyila From: targetedonc.com Several recent updates from clinical trials are transforming the treatment landscape for urothelial carcinoma across a variety of subtypes. The use of immunotherapy, in particular, provides patients who progress after standard platinum-based chemotherapy with new hope and a plethora of options. In the metastatic setting, there have been 5 immune checkpoint inhibitors approved by the …